Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019Evan M. Bloch, Kelly A. Gebo, Daniele Focosi et al.|Clinical Infectious Diseases|2023Cited by 52
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responsesPaola Mazzetti, Mauro Pistello, Maria Sidoti et al.|Journal of Clinical Virology Plus|2023Cited by 5